RxSight, Inc. RXST Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.89M-18.5% | $32.61M-18.9% | $30.34M-14.1% | $33.64M-3.6% | $37.9M+28.4% | ||
| $7.4M-22.7% | $7.35M-35.7% | $6.11M-39.4% | $8.45M-20.6% | $9.57M+8.4% | ||
| $23.5M-17.1% | $25.26M-12.2% | $24.23M-3.9% | $25.19M+3.9% | $28.33M+37.0% | ||
| 76.1%+1.3pp | 77.5%+5.9pp | 79.9%+8.4pp | 74.9%+5.4pp | 74.8%+4.7pp | ||
| $9.47M-8.6% | $8.91M-3.3% | $9.06M+2.5% | $10.22M+23.2% | $10.37M+29.1% | ||
| $31.86M+11.2% | $27.7M-1.8% | $27.35M+6.8% | $28.98M+19.3% | $28.64M+22.8% | ||
| $41.33M+6.0% | $36.6M-2.2% | $36.41M+5.7% | $39.19M+20.3% | $39M+24.4% | ||
| $41.33M+6.0% | $36.6M-2.2% | $36.41M+5.7% | $39.19M+20.3% | $39M+24.4% | ||
| -$17.83M-67.0% | -$11.34M-31.4% | -$12.18M-32.0% | -$14M-68.0% | -$10.67M0.0% | ||
| -57.7%-29.5pp | -34.8%-13.3pp | -40.1%-14.0pp | -41.6%-17.7pp | -28.2%+8.0pp | ||
| $3K-50.0% | $5K0.0% | $4K-20.0% | $5K-16.7% | $6K0.0% | ||
| $1.95M-22.1% | $2.2M-18.9% | $2.38M-18.2% | $2.25M-1.0% | $2.51M+58.2% | ||
| -$15.88M-94.3% | -$9.15M-54.4% | -$9.81M-55.0% | -$11.75M-93.9% | -$8.17M+10.1% | ||
| $6K-66.7% | $5K-58.3% | $10K-23.1% | $32K+100% | $18K+100% | ||
| -$15.88M-93.9% | -$9.15M-54.1% | -$9.82M-54.9% | -$11.79M-93.9% | -$8.19M+10.0% | ||
| -51.4%-29.8pp | -28.1%-13.3pp | -32.4%-14.4pp | -35%-17.6pp | -21.6%+9.2pp | ||
| -$0.38-90.0% | -$0.22-46.7% | -$0.24-50.0% | -$0.29-81.2% | -$0.20+20.0% | ||
| -$0.38-90.0% | -$0.22-46.7% | -$0.24-50.0% | -$0.29-81.2% | -$0.20+20.0% | ||
| 41.3M+2.0% | 40.9M+5.1% | 41M+3.0% | 40.7M+5.9% | 40.5M+10.0% | ||
| 41.3M+2.0% | 40.9M+5.1% | 41M+3.0% | 40.7M+5.9% | 40.5M+10.0% | ||
| -$16M-91.9% | -$9.16M-45.6% | -$9.64M-69.1% | -$11.92M-94.0% | -$8.34M+8.8% | ||
| $1.95M-22.1% | $2.2M-18.9% | $2.38M-18.2% | $2.25M-1.0% | $2.51M+58.2% | ||
| $30.89M-18.5% | $32.61M-18.9% | $30.34M-14.1% | $33.64M-3.6% | $37.9M+28.4% | ||
| -$17.83M-67.0% | -$11.34M-31.4% | -$12.18M-32.0% | -$14M-68.0% | -$10.67M0.0% | ||
| -$17M-71.7% | -$10.49M-29.2% | -$11.32M-39.9% | -$13.22M-75.7% | -$9.9M-3.6% | ||
| -$17M-71.7% | -$10.49M-29.2% | -$11.32M-39.9% | -$13.22M-75.7% | -$9.9M-3.6% | ||
| -55%-28.9pp | -32.2%-12.0pp | -37.3%-14.4pp | -39.3%-17.7pp | -26.1%+6.3pp | ||
| -$17.83M-67.0% | -$11.34M-31.4% | -$12.18M-32.0% | -$14M-68.0% | -$10.67M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is RxSight, Inc.'s revenue?
- RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.
- Is RxSight, Inc. profitable?
- RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.
- What are RxSight, Inc.'s profit margins?
- Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.
- What is RxSight, Inc.'s earnings per share?
- RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
- Where does RxSight, Inc.'s income statement data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
